Denoci Injection 60 mg

Get a Price/Quote

Denoci Injection 60 mg Specification

Brand Name
Denoci

Origin of Medicine
India

Packaging Type
Prefilled syringe

Salt Composition
Denosumab 60 mg

Dosage Form
Parenteral injection

Indication
Postmenopausal osteoporosis, bone loss due to hormone ablation in cancer, and prevention of skeletal-related events

Life Span
36 months from manufacturing date

Pacakaging (Quantity Per Box)
1 syringe per box

Drug Type
Biopharmaceutical monoclonal antibody

Ingredients
Denosumab (60 mg) per prefilled syringe

Physical Form
Injection

Function
Prevention and treatment of bone loss and fractures

Recommended For
Patients with osteoporosis at high risk of fractures

Dosage
60 mg subcutaneously every 6 months or as directed by physician

Dosage Guidelines
Administer subcutaneously in the upper arm, thigh, or abdomen by a healthcare professional

Suitable For
Adults; Not recommended for pregnant or lactating women

Quantity
1 prefilled syringe

Storage Instructions
Store in a refrigerator (2C-8C). Do not freeze.

Prescription/Non-Prescription
Prescription only

Minimum Order Quantity
As per customer's requirement

Side Effects
Musculoskeletal pain, hypocalcemia, risk of infections, skin reactions

Shelf Life in Months
36

Formulation
Sterile injectable solution

Route of Administration
Subcutaneous

Contraindication
Hypersensitivity to denosumab or excipients, hypocalcemia

Color
Clear, colorless to pale yellow solution

HSN Code
30029030

About Denoci Injection 60 mg

Discover the Best-seller, Denoci Injection 60 mg, a prodigious biopharmaceutical monoclonal antibody designed for the prevention and treatment of osteoporosis-related bone loss and fractures. This sterile, clear to pale yellow solution is administered subcutaneously, ensuring splendid efficacy in adults at high fracture risk. Each noble prefilled syringe comes with 60 mg of Denosumab, with a shelf life of 36 months and HSN Code 30029030. Available exclusively on prescription, Denoci is the deal your patients need-act now and Add to Cart for quality care.

Key Features and Usage Benefits of Denoci Injection 60 mg

Denoci Injection 60 mg comes as a sterile, colorless to pale yellow, prefilled syringe formulation. Intended for subcutaneous administration, it must be given by healthcare professionals in the upper arm, thigh, or abdomen. Its main advantage is the prevention and treatment of osteoporosis and bone loss due to cancers, delivered twice yearly as directed by a physician. Its noble profile and minimal dosing frequency make it highly convenient for adults seeking bone health solutions.

Sample Policy, Availability, and Export Markets for Denoci 60 mg

We provide quotations for Denoci Injection 60 mg samples based on customer requirements. Samples can be handed over upon agreement, respecting industry standards and logistics. Our main export markets encompass Asia, the Middle East, Africa, and South America, with a strong commitment to timely delivery and efficient logistics. Whether you're a wholesaler, supplier, or trader, we support your business needs with responsive sample processing and trustworthy export practices globally.

FAQ's of Denoci Injection 60 mg:

Q: How is Denoci Injection 60 mg administered?

A: Denoci Injection 60 mg is to be administered subcutaneously in the upper arm, thigh, or abdomen by a qualified healthcare professional, following your physician's prescribed dosage schedule.

Q: What are the main benefits of using Denoci Injection for osteoporosis?

A: Denoci Injection helps prevent bone loss and reduces the risk of fractures in patients with osteoporosis or cancer-related bone loss, offering long-lasting protection with only two doses per year.

Q: When should this medication be avoided?

A: Avoid Denoci Injection if you have a known hypersensitivity to denosumab or its excipients, or if you have existing hypocalcemia. It is not recommended for pregnant or lactating women.

Q: What side effects may occur with Denoci Injection 60 mg?

A: Common side effects can include musculoskeletal pain, hypocalcemia, increased risk of infections, and skin reactions. Consult your physician for a complete list and guidance.